Literature DB >> 18063077

Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.

R Zarnegar1, J Lee, L Brunaud, S Lindsay, E Kebebew, O H Clark, Q-Y Duh.   

Abstract

BACKGROUND: Spironolactone is frequently used before adrenalectomy for hyperaldosteronism to control blood pressure. Response to spironolactone has been suggested to predict a better outcome. However, whether using other antihypertensive medications to control blood pressure predicts outcome remains unknown. We sought to determine the relationship between preoperative normalization of blood pressure with antihypertensive medications and response to adrenalectomy for hyperaldosteronism.
METHOD: A retrospective cohort study of 102 patients who underwent adrenalectomy for hyperaldosteronism at a tertiary medical center were included. Blood pressures were measured at first clinical presentation, preoperatively, postoperatively, and at 1 and 6 months postoperatively. The primary outcome measure was complete resolution of hypertension (blood pressure <140/90) without antihypertensive medications, versus incomplete resolution requiring antihypertensive medications.
RESULTS: Hypertension resolved and medications were discontinued in 39% of patients. Hypertension resolved without medications in 53% of patients who were normotensive preoperatively versus 24% of patients who were hypertensive (P = .006). In contrast, hypertension resolved without medications in only 45% of patients who were normotensive on spironolactone preoperatively versus 34% of patients who were hypertensive (P = .38).
CONCLUSIONS: Patients with good preoperative control of hypertension on antihypertensive medications, irrespective of response to spironolactone, are more likely to have complete resolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063077     DOI: 10.1016/j.surg.2007.09.001

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?

Authors:  Yasutaka Baba; Sadao Hayashi; Masayuki Nakajo
Journal:  Endocrine       Date:  2012-09-19       Impact factor: 3.633

2.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

Review 3.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

4.  Predictors of successful outcome after adrenalectomy for primary aldosteronism.

Authors:  Wei Wang; WeiLie Hu; XiaoMing Zhang; BangQi Wang; Chen Bin; Hai Huang
Journal:  Int Surg       Date:  2012 Apr-Jun

5.  Long-term results of laparoscopic adrenalectomy for primary aldosteronism.

Authors:  R Campagnacci; F Crosta; A De Sanctis; M Baldarelli; G Giacchetti; A M Paganini; M Coletta; M Guerrieri
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

6.  Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis.

Authors:  Wei-Chieh Huang; Ying-Ying Chen; Yen-Hung Lin; Jeff S Chueh
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.